Business description: Wasatch Pharmaceutical, Inc.

Executive Committee: Wasatch Pharmaceutical, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Gary V. Heesch
CEO | Chief Executive Officer | - | 31/10/2010 |
| President | - | 31/10/2010 | |
Robert Meader
SAM | Sales & Marketing | - | 01/11/2010 |
Company details: Wasatch Pharmaceutical, Inc.
Wasatch Pharmaceutical, Inc.
310 East 4500 South
84107, Murray
+

Other Personal Products
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.24% | +0.99% | -6.26% | -4.20% | 341B | ||
| -0.03% | -1.18% | -10.08% | +0.51% | 135B | ||
| +0.02% | -1.57% | +5.95% | +18.93% | 69.35B | ||
| +1.23% | -0.91% | -23.98% | -20.56% | 47.47B | ||
| -0.68% | -5.99% | +9.38% | -38.60% | 34.82B | ||
| -0.50% | -3.05% | -2.30% | -15.98% | 34.42B | ||
| -0.20% | -0.20% | +1.87% | +21.61% | 20.08B | ||
| +0.24% | -2.30% | -21.11% | -38.94% | 18.76B | ||
| -0.04% | -1.82% | +5.86% | +8.52% | 18.29B | ||
| Average | +0.05% | -1.91% | -4.52% | -7.63% | 79.85B | |
| Weighted average by Cap. | +0.23% | -0.72% | -5.87% | -4.26% |

















